Found: 20
Select item for more details and to access through your institution.
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1017, doi. 10.3390/cancers12041017
- By:
- Publication type:
- Article
OAB-044: Anti-CD38 nanobodies as theranostic agents for multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S28, doi. 10.1016/S2152-2650(21)02118-2
- By:
- Publication type:
- Article
Development of <sup>177</sup>Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
- Published in:
- Contrast Media & Molecular Imaging, 2012, v. 7, n. 2, p. 254, doi. 10.1002/cmmi.491
- By:
- Publication type:
- Article
Gallium-68-labelled NOTA-oligonucleotides: an optimized method for their preparation.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 2, p. 63, doi. 10.1002/jlcr.3363
- By:
- Publication type:
- Article
Generic semi-automated radiofluorination strategy for single domain antibodies: [<sup>18</sup>F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00286-8
- By:
- Publication type:
- Article
Radiotheranostic Agents in Hematological Malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.911080
- By:
- Publication type:
- Article
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01171-6
- By:
- Publication type:
- Article
Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
- Published in:
- Contrast Media & Molecular Imaging, 2014, v. 9, n. 3, p. 211, doi. 10.1002/cmmi.1558
- By:
- Publication type:
- Article
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1941, doi. 10.2967/jnumed.123.266381
- By:
- Publication type:
- Article
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 751, doi. 10.2967/jnumed.122.264752
- By:
- Publication type:
- Article
A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 493, doi. 10.2967/jnumed.122.264453
- By:
- Publication type:
- Article
A Realistic Multi-region Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264453
- By:
- Publication type:
- Article
Phase I trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.255679
- By:
- Publication type:
- Article
Assessment of mouse-specific pharmacokinetics in kidneys based on <sup>131</sup>I activity measurements using micro-SPECT.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00443-5
- By:
- Publication type:
- Article
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1378, doi. 10.3390/pharmaceutics15051378
- By:
- Publication type:
- Article
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 8, p. 376, doi. 10.3390/pharmaceutics11080376
- By:
- Publication type:
- Article
Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 885, doi. 10.2967/jnumed.117.199901
- By:
- Publication type:
- Article
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using <sup>18</sup>F-Radiolabeled Camelid Single-Domain Antibody Fragments.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 8, p. 1265, doi. 10.2967/jnumed.115.156828
- By:
- Publication type:
- Article
SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 5, p. 807, doi. 10.2967/jnumed.112.111781
- By:
- Publication type:
- Article
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of <sup>68</sup>Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 5, p. 776, doi. 10.2967/jnumed.112.111021
- By:
- Publication type:
- Article